Thought leadership on AI governance, institutional authority, and the human architecture that determines whether AI strengthens or destabilizes your organization.
In short: Falkovia’s Insights examine the human architecture beneath AI governance, including decision authority, override protocols, incident response, and board and regulator readiness. Written for executives in healthcare systems, universities, and investment firms who carry institutional, fiduciary, and reputational risk as AI scales.
AI governance is moving from policy aspiration to architectural requirement. State legislatures, accreditation bodies, federal agencies, and the courts are all converging on the same expectation: institutional leadership must be able to document who governs AI, where the Human Authority Line is drawn, and how decisions hold under scrutiny.
These articles examine the human substrate that determines whether AI strengthens or destabilizes institutions. Decision authority. Override protocols. Board and regulator readiness. Written for executives in healthcare systems, higher education institutions, and venture capital and private equity firms carrying institutional, fiduciary, and reputational risk.
The higher a leader rises, the fewer places their thinking gets challenged before it becomes a decision. AI can close that gap or quietly widen it, and the difference comes down to one choice: is it being used as a mirror, or a thinking partner.
Read more →A university board carries a fiduciary duty to oversee AI risk. These are the questions a president and board should be able to answer, why they matter, and where they align with NIST, ISO, and the EU AI Act.
Read more →A compliance audit checks the AI against a standard. Governance that actually reduces risk includes more: the human decisions and accountability around the tool. Here is the difference, and why regulators are now asking for it.
Read more →The people who authorize an AI rollout trust the technology. The people who use it often do not, and that gap, hard to see from where AI is decided, is where most AI value quietly leaks away.
Read more →At exit, a portfolio company built on AI is worth what an acquirer believes that AI will keep producing, and how acquirers price that AI is changing. A pre-exit review builds governance that meets the market you will actually exit into, so the AI reads as an asset rather than an exposure.
Read more →When you back a company for the AI it builds, your deal model prices the value that AI will produce. The question that sits between your technical and legal diligence can decide whether that value lasts: can the company govern its AI well enough to hold up under scrutiny?
Read more →AI is already shaping clinical decisions, from early-warning alerts to decision support. The real question is who holds authority over it: when a clinician's judgment governs, and who is accountable for the outcome. This is how to design that structure so it holds with the clinicians who live inside it.
Read more →Accreditors are beginning to ask how institutions govern AI. What they want to see is who holds authority over it and who is accountable, documented as decision rights rather than described in a policy. This is how to establish them before a review.
Read more →The 2025 research on why AI initiatives stall points in one direction, and it is not the technology. For regulated institutions, the approach that matters most is the one that governs the human layer your policies and platforms stand on.
Read more →When a board asks about AI decision authority, the answer is not a policy on its own. The board needs a name, evidence a person can act, and the documentation behind it. That is the difference between having a policy and governing AI.
Read more →On TechRound: why most AI initiatives fail, and what changes when governance becomes the foundation, not the afterthought.
Read more →Most institutions treat a regulatory audit as the reason to build AI governance. The audit is the test. Governance is what you build so the test reveals strength rather than exposure.
Read more →Most boards receive AI status reports. Board-ready governance documentation is an accountability architecture that answers the questions regulators, accreditors, and litigants are now asking.
Read more →Why the biggest liability in your portfolio company isn't in the model. It's in the human governance architecture that standard diligence never examines.
Read more →The governance question every university president needs to answer before their accreditor asks it.
Read more →Healthcare's next leadership question isn't whether AI works. It's whether your human authority architecture was designed before AI started making decisions.
Read more →Analysis of the human architecture beneath AI governance: decision authority, override protocols, incident response, and board and regulator readiness. Written for executives in healthcare systems, higher education institutions, and investment firms who carry institutional, fiduciary, and reputational risk as AI scales.
Dr. Tiffany Masson, Psy.D., founder of Falkovia, a clinical and forensic psychologist and founding university president who built a medical school under active accreditation and regulatory scrutiny. Each article draws on what she sees inside live engagements with healthcare CEOs, university presidents, and investment firm leaders governing AI in regulated institutions.
Most AI governance writing focuses on policy documents and compliance checklists. Falkovia’s Insights examines the layer underneath: who holds decision authority when AI is wrong, where the Human Authority Line is drawn, and how governance holds under regulatory, accreditation, and board scrutiny. The frame is human architecture, not technology.
Yes. Articles address AI governance across all three sectors: clinical AI authority in healthcare, accreditation and decision rights in higher education, and pre-acquisition and portfolio governance in investment firms.
Yes. Every article is free, with no gate or paid tier.
New articles are added as the governance questions facing boards, health system leaders, and university presidents evolve, alongside The Blind Spot, Falkovia’s weekly newsletter.